1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC
1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC (1-Myistoyl-d7-2-Lioleoyl-s-glyceo-3-Phosphatidylcholie, 1-Myistoyl-d7-2-Lioleoyl-s-glyceo-3-Phosphocholie, PC (14:0-d7/18:2), 14:0-d7/18:2-PC) is deuterium labeled 1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC[1].
Product Specifications
Product Name Alternative
1-Myistoyl-d7-2-Lioleoyl-s-glyceo-3-Phosphatidylcholie, 1-Myistoyl-d7-2-Lioleoyl-s-glyceo-3-Phosphocholie, PC (14:0-d7/18:2), 14:0-d7/18:2-PC
UNSPSC
12352211
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Smiles
O=C(OC[C@H](COP(OCC[N+](C)(C)C)([O-])=O)OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)CCCCCCCCCCC([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H]
Molecular Formula
C40H69D7NO8P
Molecular Weight
737.05
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 17 (E3), CF647 conjugate, 0.1mg/mL
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF594 conjugate, 0.1mg/mL
B7-H4 (Immuno-Inhibitory Protein) (B7H4/2652R), CF640R conjugate, 0.1mg/mL
